Circumscribed myxedema of the arms and legs - An uncommon cutaneous manifestation of Graves disease. Case report and literature review;Zirkumskriptes myxödem der oberen und unteren extremitäten - Eine seltene kutane manifestation des morbus basedow. Fallbeispiel und literaturübersicht

Hautarzt

Volumn 52, Issue 5, 2001, Pages 439-443

  Mooser, Georg ^a   Weber, L ^b   Kerscher, M ^b   Peter, R U ^b  

^a UNIVERSITY OF ULM   (Germany)

^b NONE

Author keywords

Bath PUVA therapy; Circumscribed myxedema; Graves' disease; Infiltrative ophthalmopathy; Mucinosis

Indexed keywords

RADIOACTIVE IODINE;

ADULT; ARM; ARTICLE; BALNEOTHERAPY; CASE REPORT; DECOMPRESSION SURGERY; EYE DISEASE; GRAVES DISEASE; HUMAN; LEG; MALE; MYXEDEMA; PATHOGENESIS; PUVA; RADIOISOTOPE THERAPY;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; EXTREMITIES; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED; MYXEDEMA; PATIENT CARE TEAM; SKIN;

EID: 0342960931     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050051339     Document Type: Article

References (16)

1. Antonelli A, Navarranne A, Palla R et al. (1994) Pretibial myxedema and high-dose intravenous immunglobulin treatment. Thyroid 4:399-408
2. Braun-Falco O, Petzoldt D (1967) E.M.O.-Syndrom. Exophthalmus, Myxödema circumscriptum praetibiale und Osteoarthropathia hypertrophicans (E.M.O.-Syndrom). Muenchn Med Wochenschr 79:1523-1529
3. Chang TC, Kao SCS, Huang KM (1992) Octreotide and Graves'ophthalmopathy and pretibial myxoedema. Br Med J 304:158
4. Fatourechi V, Pajouhi M, Fransway AF (1994) Dermopathy of Graves' disease (pretibial myxedema). Medicine 73:1-7
5. Göring HD, Ziemer A (1989) Immunopathogenetische, endokrinologische und therapeutische Probleme des EMO-Syndroms. Dermatol Monatsschr 175:492-498
6. Heufelder AE, Smith TJ, Gorman CA, Bahn RS (1991) Increased induction of HLA-DRby interferon-gamma in cultured fibroblasts derived from patients with Graves' disease ophthalmopathy and pretibial dermopathy. J Clin Endocrinol Metab 73:739-745
7. Hierholzer K, Finke R (1997) Myxedema. Kidney Int 51 [Suppl 59]:82-89
8. Kriss JP (1987) Autoimmune thyroid disease, pathogenesis and treatment of pretibial myxedema. Endocrinol Metab Clin North Am 16:409-415
9. Kriss JP, Pleshakov V, Chien JR (1964) Isolation and identification of long-acting thyroid stimulator and its relation to hyperthyroidism and circumscribed pretibial myxedema. J Clin Endocrinol Metab 24:1005-1028
10. Lynch PJ, Maize JC, Sisson JC (1973) Pretibial myxedema and nonthyrotoxic thyroid disease. Arch Dermatol 107:107-111
11. Sauer P, Brandes B, Mahmarian RR (1995) Lower extremity manifestations of Graves' disease. J Foot Ankle Surg 34:489-497
12. Schirren CG, Betke M, Eckert F et al. (1992) Skleromyxödem Arndt-Gottron. Fallbericht und Übersicht über die therapeutischen Möglichkeiten. Hautarzt 43:152-157
13. Shishiba Y, Imai Y, Odajima R, Ozawa Y, Shimizu T (1992) Immunoglobulin G of patients with circumscribed pretibial myxedema of Grave's disease stimulates proteoglycan synthesis in human skin fibroblasts in culture Acta Endocrinol 127:44-51
14. Smith TJ (1991) Localized myxoedema and thyroid acropathy. In: Braverman LE, Utiger RD (eds) The thyroid. Lippincott, Philadelphia, pp 667-668
15. Wartowsky L (1998) Graves'disease. In: Fauci AS, Braunwald E, Isselbacher KJ et al. (eds) Harrison's principles of internal medicine. McGraw-Hill Health Professions Division, pp 2023-2028
16. Weetman AD, Volkman DJ, Burman KD, Gernard TL, Fauci AS (1981) The in vitro regulation of human thyrocyte HLA-DR antigen expression J Clin Endocrinol Metab 61:817-825